Navigation Links
In Support of World AIDS Day, FHSSA Announces New Partnerships That Include the First In-Country Partnerships in Namibia and The Gambia
Date:12/1/2008

ALEXANDRIA, Va., Dec. 1 /PRNewswire-USNewswire/ -- Today, more than 740 children will die of AIDS. In fact, nearly 7,000 people die each day due to HIV/AIDS.

December 1 is World AIDS Day, a day of awareness and outreach to help people worldwide understand the impact of HIV/AIDS. A central theme for World AIDS Day 2008 is You Can Make a Difference and the focus is two-fold, that of bringing people together to talk about HIV as well as helping dispel the myths and misconceptions about HIV.

The Foundation for Hospices in Sub-Saharan Africa's (FHSSA) partnering initiative links African hospices and palliative care providers with American hospices and organizations for support, financial assistance, and technical assistance. Through FHSSA's partnering initiative, 75 U.S. organizations in 27 states are partnered with a hospice in one of 16 African countries. These U.S. and African care providers have joined together to make a real difference for those suffering with HIV/AIDS, cancer, and other life threatening illnesses.

In many countries in Africa there is little or no access to adequate pain medication, little or no access to hospice and palliative care, and desperate situations of suffering, stigma, poverty, and isolation. This is particularly acute for women and children. Yet FHSSA's partners are doing what they can to make a profound difference and on World AIDS Day, FHSSA is proud to announce the addition of six new hospice partnerships:

  • Evercare Hospice and Palliative Care in Virginia with Evangelical Lutheran Church AIDS Programme, the first in-country partnership in Namibia
  • United Hospice of Rockland County in New York with Choice Trust in South Africa
  • VITAS Innovative Hospice Care of Brevard in Florida with St. Francis Kouga Hospice in South Africa
  • VITAS Innovative Hospic
    '/>"/>

SOURCE Foundation for Hospices in Sub-Saharan Africa
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Serotek First to Offer 64-Bit Support
2. In Recognition of WORLD AIDS DAY, Charlotte Bobcats Power Forward, Emeka Okafor, Launches Mobile Texting Campaign in Support of the One Million African Lives Initiative
3. CNSI Selects Edifecs Healthcare Accelerator Suite(TM) for MMIS Solution to Support South Dakota Medicaid Program
4. Top Athletes Join Forces for a New Mission: Athlete-Engineered Skincare to Support Performance and Benefit Charity
5. Free Home Business to Individuals Recovering from Alcoholism Provided by AlcoholSupportGroup.com
6. CVS/pharmacy Raising Funds for the St. Jude Childrens Research Hospital(R) Thanks and Giving(R) Campaign to Support Expanded Rehabilitation Services Center
7. Marlo Thomas and St. Jude Childrens Research Hospital(R) Kick Off The 5th Anniversary of the Thanks and Giving(R) Campaign Asking America to Support St. Jude While Shopping this Holiday Season
8. Sermes CRO Deploys Oracle(R) Clinical Applications to Support Growth
9. ALDO Supports World AIDS Day by Donating 100% of Proceeds for Newest ALDO Fights Aids Product
10. Minnesota Nurses Support SEIU Workers at Regina Medical Center, Hastings
11. National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Animal studies suggest that adding flaxseed oil to... post-menopausal women and women with diabetes, ac...ational Journal of Food Safety, Nutrition and Publ...tional Research Center, in Cairo, Egypt, have stud...uated how flaxseed oil in the diet might delay the...
(Date:11/23/2009)...Since 1996, crop plants genetically modified to pr... insects, yet safe for people, have been planted o...pularity of these Bt crops, named after the bacter...lity to kill some major pests, allowing farmers to...ducing insecticide sprays. , However, since inse...
(Date:11/23/2009)...ding drug to chemo regimen may improve patient out.... 23 (HealthDay News) -- A new combination drug th...nced biliary-tract cancers, researchers say. , ...Cancer Center in Boston found that survival and tu...(Avastin), an angiogenesis inhibitor that has help...
(Date:11/23/2009)...V patients who have it take longer to get sick, st... News) -- Scientists report that a genetic variati... progression in HIV-infected patients. , In f... longer to develop AIDS and die of complications o...that vary across individuals that make a person mo...
(Date:11/23/2009)...,, ,, NASHVILLE,Tenn.,Nov.23/PRNewswire...gedcaremarketintelligence,reportsthatself-insuredm...thCareGrouphaveexperiencedanaggregatehealthcare-co...tthreeyearsofparticipationinahigh-performanceprovi... thecoalitionfoundtheseself-insuredmembercompanies...
Breaking Medicine News(10 mins):Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2Health News:Milwaukee Employers See Cost Savings with High-Performance Provider Network 2
...is about the same as using drugs for treatment, st...y News) -- Giving blood transfusions to treat anem...ially lethal blood clots, say University of Roches...lyzed data on more than 70,500 cancer patients who...
...28 HMS Holdings Corp.,(Nasdaq: HMSY ) today ann...er,Jaffray Healthcare Conference, which will be he.... , Walter Hosp, CFO, will present on Tuesday, D...rity services for government healthcare programs.,...
...ght boost understanding of the disease generally, ...hDay News) -- The adult children of people with th... being sought for a new study to better understand...nset form of Alzheimer,s are needed for the six-ye...
...cals make some playthings unfit for kids, report c... -- Plastic fish squirt guns and plastic ponies co...ates. , Toy cars and toy earrings laced with lead....day season, but that they shouldn,t find their way...
..., Nov. 28 VIDA Diagnostics Inc. announced,today t... (PW2) has obtained,FDA 510(k) clearance for sale....ng image analysis software from,VIDA and comprises...ystem measurement functions. , "We are privi...
... Serving as a model for public health a...organization has launched the D*action Community P...nd individuals committed to solving the worldwide ... p.m. , San Diego, CA (PR...
Other Medicine News:Health News:Transfusing Anemic Cancer Patients Boosts Clot Risk 2Health News:Study Recruiting From Alzheimer's-Prone Families 2Health News:Beware of Toxic Toys This Holiday Season 2Health News:Beware of Toxic Toys This Holiday Season 3Health News:VIDA Diagnostics Gains FDA Approval for Comprehensive Lung Analysis Software 2Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 2Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 3
(Date:11/23/2009)...BridgePointMedicalannouncedtodaythatitreceivedEuro...ripheralChronicTotalOcclusion(CTO)CrossingSystemco...Stingray®CTORe-EntrySystem.TheBridgePointSyst...dtonavigatehighlydiseasedarteriesinpreparationforb..., TheNationalHeart,LungandBloodInstitute(NHLBI)est...
(Date:11/23/2009)...wire-FirstCall/-- LexiconPharmaceuticals,Inc. (Nas...hase2clinicalstudywith LX1031 inpatientswithnon-co...edatGASTRO2009inLondonthisweek.Resultsfromthestudy...illbepresentedbyDr. PhilipM.Brown ,Lexicon,ssenior...09at2:30pmlocaltimeatthesessionentitled,"Therapeut...
(Date:11/23/2009)...e-FirstCall/--WoundManagementTechnologies,Inc.,(OT...altymedicalproducts,announcedthatithasfileditQ3200...ementbusinessupdatetoillustratethedevelopmentsduri...33.5%to$102,926vs.Q32008salesof$77,084. , Sha....Q32008shareholderequityof$(321,257) , Totala...
Breaking Medicine Technology:BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Obama Signs Tough New Anti Smoking Law 49671 1Obama Signs Tough New Anti Smoking Law 49671 2Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 1Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 2Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 3Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 4Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 5Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 6Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 7Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 1Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 2
... Va., Jan. 4 Innocoll, Inc., a privately-held,spe...first of a series of,planned phase 2 clinical tria...ll Technologies Ltd, to investigate CollaRx(R) BUP...st-operative pain, has commenced dosing., Innocol...e and fully,bioresorbable matrix of purified fibri...
...Calif., Jan. 3 Watson,Pharmaceuticals, Inc. (NYSE...ny, announced today it has launched Clarithromycin...gth. Watson,s Clarithromycin,Extended-Release prod...),XL, which is indicated to treat or prevent infec...caused by susceptible bacteria. For the 12-months,...
Other Medicine Technology:Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 4Watson Launches Generic Biaxin(R) XL 2
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: